References
- LiaoYTLiuCHYuJWuKCLiver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheresInt J Nanomedicine201492767277824940057
- HuCMZhangLNanoparticle-based combination therapy toward overcoming drug resistance in cancerBiochem Pharmacol20128381104111122285912
- ZhangXGuoSFanRDual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cellsBiomaterials201233297103711422796159
- ZhangXJZhangXGYuPEHanYCLiYGLiCXHydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatomatargeting drug delivery systemJ Pharm Sci2013102114515323132353
- XunSFangWWeiLZhangZRSustained-release hydroxycamptothecin polybutylcyanoacrylate nanoparticles as a liver targeting drug delivery systemPharmazie2004591079179415544059
- ChengMGaoXWangYSynthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivoInt J Nanomedicine201384265427624232303
- MaoSJBiYQJinHWeiDPHeRHouSXPreparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acidPharmazie200762861461917867558
- HuangWWangWWangPGlycyrrhetinic acid-modified poly(ethylene glycol)-b-poly(gamma-benzyl l-glutamate) micelles for liver targeting therapyActa Biomater20106103927393520438873
- ZhangCWangWLiuTDoxorubicin-loaded glycyrrhetinic acid-modified alginate nanoparticles for liver tumor chemotherapyBiomaterials20123372187219622169820
- ZhaoDZhaoXZuYPreparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticlesInt J Nanomedicine2010566967720957218
- LangerKBalthasarSVogelVDinauerNvon BriesenHSchubertDOptimization of the preparation process for human serum albumin (HSA) nanoparticlesInt J Pharm20032571–216918012711172
- KommareddySAmijiMPreparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathioneBioconjug Chem20051661423143216287238
- AzarmiSTaoXChenHFormulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particlesInt J Pharm20063191–215516116713150
- ElzoghbyAOSamyWMElgindyNAAlbumin-based nanoparticles as potential controlled release drug delivery systemsJ Control Release2012157216818221839127
- ZuYGZhangYZhaoXHZhangQLiuYJiangROptimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM)Int J Nanomedicine2009432133320054435
- MieleESpinelliGPMieleETomaoFTomaoSAlbumin-bound formulation of paclitaxel (Abraxane (R) ABI-007) in the treatment of breast cancerInt J Nanomedicine2009419910519516888
- JainDBanerjeeRComparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug deliveryJ Biomed Mater Res B Appl Biomater200886110511218098198
- ArnedoAIracheJMMerodioMEspuelas MillanMSAlbumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotideJ Control Release200494121722714684285
- UlbrichKHekmataraTHerbertEKreuterJTransferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB)Eur J Pharm Biopharm200971225125618805484
- SteinhauserIMLangerKStrebhardtKMSpankuchBEffect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturationBiomaterials200829294022402818653231
- WilsonBAmbikaTVPatelRDKJenitaJLPriyadarshiniSRBNanoparticles based on albumin: preparation, characterization and the use for 5-flurouracil deliveryInt J Biol Macromol201251587487822820011
- QianHYangYWangXCurcumin enhanced adriamycin-induced human liver-derived hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagyEur J Pharm2011433125131
- CaoJLiuYJiaLCurcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cellsFree Radic Biol Med200743696897517697941
- WangMRuanYXChenQALiSPWangQLCaiJYCurcumin induced HepG2 cell apoptosis-associated mitochondrial membrane potential and intracellular free Ca2+ concentrationEur J Pharmacol20116501414720883687
- Syng-aiCKumariALKharAEffect of curcumin on normal and tumor cells: Role of glutathione and bcl-2Mol Cancer Ther2004391101110815367704
- KunwarABarikAMishraBRathinasamyKPandeyRPriyadarsiniKIQuantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cellsBiochim Biophys Acta20081780467367918178166
- HatcherHPlanalpRChoJTortiaFMTortiSVCurcumin: from ancient medicine to current clinical trialsCell Mol Life Sci200865111631165218324353
- KumarVLewisSAMutalikSShenoyDBVenkateshUdupaNBiodegradable microspheres of curcumin for treatment of inflammationIndian J Physiol Pharmacol200246220921712500496
- FanHTianWMaXCurcumin induces apoptosis of HepG2 cells via inhibiting fatty acid synthaseTarget Oncol20149327928623821378
- LouJHuWTianROptimization and evaluation of a thermo-responsive ophthalmic in situ gel containing curcumin-loaded albumin nanoparticlesInt J Nanomedicine201492517252524904211
- ZhangLHouSMaoSWeiDSongXLuYUptake of folate-conjugated albumin nanoparticles to the SKOV3 cellsInt J Pharm20042871–215516215541922
- ZhangLKHouSXZhangJQHuWJWangCYPreparation, characterization, and in vivo evaluation of mitoxantrone-loaded, folate-conjugated albumin nanoparticlesArch Pharm Res20103381193119820803122
- LuYLiJWangGIn vitro and in vivo evaluation of mPEG-PLA modified liposomes loaded glycyrrhetinic acidInt J Pharm20083561–227428118304766
- ChengMXuHWangYGlycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cellsDrug Des Devel Ther2013712871299
- LiuJXuHZhangYNovel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin deliveryInt J Nanomedicine2014919720724399876